|
|
Blood, 15 April 2007, Vol. 109, No. 8, pp. 3284-3290.
Prepublished online as a Blood First Edition Paper on December 14, 2006; DOI 10.1182/blood-2006-10-051664.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Structure-function analysis reveals discrete ß3 integrin inside-out and outside-in signaling pathways in platelets
Zhiying Zou1,
Hong Chen1,
Alec A. Schmaier1,
Richard O. Hynes2, and
Mark L. Kahn1
1 Division of Cardiology and Department of Medicine, University of Pennsylvania, Philadelphia;
2 Center for Cancer Research, Massachusetts Institute of Technology, Cambridge
A unique aspect of integrin receptor function is the transmission of bidirectional signals. In platelets  IIbß3 integrins require "inside-out" signals to bind fibrinogen and form thrombi. Following ligand binding, IIbß3 integrins generate "outside-in" signals that contribute to thrombus stability. Because integrin cytoplasmic tails are short and lack enzymatic activity, bidirectional signals are believed to be mediated by interactions with intracellular proteins, but the molecular basis for integrin signal transduction remains poorly understood. In the present study we have used retroviral vectors to express IIbß3 integrins with mutant ß3 tails in mouse platelets and test mechanisms of bidirectional signaling. Using this approach we identify mutations (eg, ß3Y747A) that confer loss of signaling in both directions and others (eg, ß3T762A) that confer a selective loss of outside-in signals. These results reveal the presence of discrete bidirectional signaling pathways controlled by integrin ß subunits in platelets and describe a high-throughput means of further investigating these pathways in vivo.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Inside-out, outside-in: what's the difference?
- Edward F. Plow and Yan-Qing Ma
Blood 2007 109: 3128-3129.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
R. Blue, M. A. Kowalska, J. Hirsch, M. Murcia, C. A. Janczak, A. Harrington, M. Jirouskova, J. Li, R. Fuentes, M. A. Thornton, et al.
Structural and therapeutic insights from the species specificity and in vivo antithrombotic activity of a novel {alpha}IIb-specific {alpha}IIb{beta}3 antagonist
Blood,
July 2, 2009;
114(1):
195 - 201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Zou, A. A. Schmaier, L. Cheng, P. Mericko, S. K. Dickeson, T. P. Stricker, S. A. Santoro, and M. L. Kahn
Negative regulation of activated {alpha}2 integrins during thrombopoiesis
Blood,
June 18, 2009;
113(25):
6428 - 6439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Ablooglu, J. Kang, B. G. Petrich, M. H. Ginsberg, and S. J. Shattil
Antithrombotic effects of targeting {alpha}IIb{beta}3 signaling in platelets
Blood,
April 9, 2009;
113(15):
3585 - 3592.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Coller and S. J. Shattil
The GPIIb/IIIa (integrin {alpha}IIb{beta}3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
Blood,
October 15, 2008;
112(8):
3011 - 3025.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bouaouina, Y. Lad, and D. A. Calderwood
The N-terminal Domains of Talin Cooperate with the Phosphotyrosine Binding-like Domain to Activate {beta}1 and {beta}3 Integrins
J. Biol. Chem.,
March 7, 2008;
283(10):
6118 - 6125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Flevaris, A. Stojanovic, H. Gong, A. Chishti, E. Welch, and X. Du
A molecular switch that controls cell spreading and retraction
J. Cell Biol.,
November 5, 2007;
179(3):
553 - 565.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
